Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 15 Jul 2025

Systemic evaluation of inclisiran on the risk of new-onset diabetes and hyperglycemia compared to evolocumab and atorvastatin

in Pharmacoepidemiology

Fei Li
Huan Ye
Lingbin Chen
Yuanchun Ma
Sunhui Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554631

4,235 views
1 citation

Original Research

Published on 14 Jul 2025

Patterns and predictors of self-medication behavior of weight loss medications: a cross-sectional analysis of social media influence and role of pharmacist intervention

in Pharmacoepidemiology

Neven Sarhan
Mona F. Schaalan
Azza A. K. El-Sheikh

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1606566

6,251 views
3 citations

Original Research

Published on 11 Jul 2025

Factors associated with prescription of modern antidiabetics in newly diagnosed patients with type 2 diabetes. a real-world data study in a Spanish region

in Pharmacoepidemiology

Irantzu Bengoa-Urrengoechea
Isabel Aguilar-Palacio
María José Rabanaque
María Jesús Lallana
Adriana Gamba Cabezas
Sara Malo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1530139

1,976 views

Review

Published on 10 Jul 2025

Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice

in Pharmacoepidemiology

Michela De Bellis
Giuseppe d’Orsi
Egidio Maria Rubino
Claudia Arigliano
Massimo Carella
Vittorio Sciruicchio
Antonella Liantonio
Annamaria De Luca
Paola Imbrici

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584566

9,219 views
4 citations

General Commentary

Published on 07 Jul 2025

Commentary: Anti-TNFα in inflammatory bowel disease: from originators to biosimilars

in Pharmacoepidemiology

Yingjie Liu
Keying Wang
Wenjiang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1625961

1,506 views

Original Research

Published on 04 Jul 2025

From prescription patterns to drug safety: a closer look at non-steroidal anti-inflammatory drugs and analgesics in outpatient pharmacy

in Pharmacoepidemiology

Zainab Mohamed Saeed
Sathvik B. Sridhar
Javedh Shareef
Amal Mohamed Rashed Alsereidi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558830

4,085 views
3 citations

Systematic Review

Published on 03 Jul 2025

A systematic review and meta-analysis on how different dexamethasone administration regimes impact total joint arthroplasty outcomes

in Pharmacoepidemiology

Can Wang
Chenjing Luo
Xiaoxue Tang
Li Luo
Yuerong Zeng
Yumei Zhang
Xuan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548126

2,893 views
1 citation

Systematic Review

Published on 02 Jul 2025

Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis

in Pharmacoepidemiology

Peipei Li
Weiwei Chen
Rui Chen
Hanmo Zhang
Zhixi Yu
Hongyu Yan
Beibei Du
Ping Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558367

3,147 views
1 citation

Original Research

Published on 02 Jul 2025

Antidepressant use in the Canary Islands (Spain): a retrospective study of provincial, island and municipal trends and associated factors

in Pharmacoepidemiology

Alexis Oliva
Vanessa Moreno
Mariana Sapino
Sandra Dévora
Susana Abdala-Kuri

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1511936

2,048 views

Original Research

Published on 01 Jul 2025

Antihypertensive medications and cancer risk: Evidence from 0.27 million patients with newly diagnosed hypertension

in Pharmacoepidemiology

Huan Yu
Zhike Liu
Yiqun Wu
Liuyan Zheng
Kun Wang
Jingxian Wu
Huairong Wang
Kexin Ding
Ruotong Yang
Huziwei Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559604

2,722 views
1 citation

Original Research

Published on 30 Jun 2025

Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)

in Pharmacoepidemiology

Xiang Li
Si-Qi Zhang
Ke-Rui Wang
Shi-Nan Wu
Meng-Yuan Wang
Cui-Ting Chen
Nuo Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1498814

3,916 views
1 citation

Original Research

Published on 30 Jun 2025

Cost-effectiveness of therapeutic drug monitoring of perampanel for pediatrics with epilepsy: real-world data

in Pharmacoepidemiology

Yani Hu
Pu Miao
Shunan Chen
Fengqian Mao
Suhong Wang
Jianhua Feng
Jie Chen
Lingyan Yu
Haibin Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549069

1,904 views
2 citations

Original Research

Published on 27 Jun 2025

Pharmacovigilance-related events, disease burden and overall efficiency of care in european countries, 1990-2021

in Pharmacoepidemiology

Lin Yin
Shuzhi Lin
Qian Liu
Xiaoying Zhu
Wei Liu
Yifang Shen
Zimeng Li
Bianling Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592957

1,681 views

Original Research

Published on 26 Jun 2025

Drug-associated hearing impairment in children: a disproportionality analysis of the FDA adverse event reporting system

in Pharmacoepidemiology

Jinfeng Liu
Junyi Tan
Qinli Xiao
Yingtao Bai
En Chang
Chun Su
Yuxun Wei
Hu Zhong
Wei Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532461

3,163 views
1 citation

Original Research

Published on 23 Jun 2025

Adverse drug reaction signal detection via the long short-term memory model

in Pharmacoepidemiology

Mengqi Cao
Yanna Chi
Jinyang Yu
Yu Yang
Ruogu Meng
Jinzhu Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554650

2,798 views
1 citation

Original Research

Published on 20 Jun 2025

Application and evaluation of the global trigger tool approach to adverse drug event monitoring in the high-risk elderly inpatients with multiple chronic diseases

in Pharmacoepidemiology

Na Li
Xiao-Min Lv
Chen-Yang Jiao
Dong-Li Zhang
Lin-Wei Chen
Yi-Ling Chang
Jin-Fang Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594176

1,749 views

Original Research

Published on 18 Jun 2025

Comparative analysis of thrombocytopenia incidence in patients treated with generic vs. brand-name linezolid: a cohort study utilizing hospital electronic medical records

in Pharmacoepidemiology

Zhizhou Wang
Ke Wang
Yiming Hua
Xin Hu
Xiaotong Zhang
Xiaoxi Li
Xiaoxuan Xing
Yingnan Feng
Chao Wu
Zhichao Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1528633

1,717 views

Original Research

Published on 18 Jun 2025

What drives hyperammonemic encephalopathy in AED users: monotherapy risks or polypharmacy perils?

in Pharmacoepidemiology

Qing Shan
Lei Wang
Xia Liu
Yan Chen
Bing Li
Yuhang Guo
Qiang Fu
Jinmin Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1477127

2,992 views

Original Research

Published on 12 Jun 2025

Heart failure medication treatment and prognosis: a retrospective cross-sectional study

in Pharmacoepidemiology

Qiankai Lin
Zongjie Lv
Daiyi Li
Qiao Ling
Sha Qiu
Xiaomei Lei
Fang Qin
Na Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532123

4,182 views

Original Research

Published on 11 Jun 2025

Influence of the estimated glomerular filtration rate equation on carboplatin dosing: a real-world study

in Pharmacoepidemiology

Ana Rita Fortunato
Cátia Barbosa
Ariana Araujo
Fernando Fernandez-Llimos

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1605458

2,271 views

Original Research

Published on 10 Jun 2025

Exploring multidimensional determinants of medication error reporting in China: a qualitative study using the theoretical domains framework

in Pharmacoepidemiology

Hui Guo
Qian Guo
Xiuping Wang
Yonghong Liu
Ze Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590794

2,876 views

Original Research

Published on 09 Jun 2025

Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024

in Pharmacoepidemiology

Siyu Lou
Huayou Chen
Zhiwei Cui
Xiyuan Zhang
Chengyu Zhu
Linmei Zhou
Yingyong Ou
Fan Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516449

5,538 views
4 citations

Original Research

Published on 30 May 2025

Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery

in Pharmacoepidemiology

Zichao Ji
Xin Wang
Jiawei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1553221

2,467 views
2 citations

Original Research

Published on 30 May 2025

Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system

in Pharmacoepidemiology

Wensheng Liu
Feifei Gao
Xue Song
Hao Chen
Youjun She
Jiyong Liu
Qiong Du

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558128

5,393 views
4 citations

602 articles

articles

Systemic evaluation of inclisiran on the risk of new-onset diabetes and hyperglycemia compared to evolocumab and atorvastatin

Patterns and predictors of self-medication behavior of weight loss medications: a cross-sectional analysis of social media influence and role of pharmacist intervention

Factors associated with prescription of modern antidiabetics in newly diagnosed patients with type 2 diabetes. a real-world data study in a Spanish region

Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice

Commentary: Anti-TNFα in inflammatory bowel disease: from originators to biosimilars

From prescription patterns to drug safety: a closer look at non-steroidal anti-inflammatory drugs and analgesics in outpatient pharmacy

A systematic review and meta-analysis on how different dexamethasone administration regimes impact total joint arthroplasty outcomes

Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis

Antidepressant use in the Canary Islands (Spain): a retrospective study of provincial, island and municipal trends and associated factors

Antihypertensive medications and cancer risk: Evidence from 0.27 million patients with newly diagnosed hypertension

Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)

Cost-effectiveness of therapeutic drug monitoring of perampanel for pediatrics with epilepsy: real-world data

Pharmacovigilance-related events, disease burden and overall efficiency of care in european countries, 1990-2021

Drug-associated hearing impairment in children: a disproportionality analysis of the FDA adverse event reporting system

Adverse drug reaction signal detection via the long short-term memory model

Application and evaluation of the global trigger tool approach to adverse drug event monitoring in the high-risk elderly inpatients with multiple chronic diseases

Comparative analysis of thrombocytopenia incidence in patients treated with generic vs. brand-name linezolid: a cohort study utilizing hospital electronic medical records

What drives hyperammonemic encephalopathy in AED users: monotherapy risks or polypharmacy perils?

Heart failure medication treatment and prognosis: a retrospective cross-sectional study

Influence of the estimated glomerular filtration rate equation on carboplatin dosing: a real-world study

Exploring multidimensional determinants of medication error reporting in China: a qualitative study using the theoretical domains framework

Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024

Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery

Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system